Press Releases

α-GalCerを活用した新しいがん免疫療法を開発
- 生体内樹状細胞の成熟で、さまざまながん細胞を排除 -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

New 7DW8-5 glycolipid

7DW8-5

Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch

 

Meet Funakoshi Company
at the following meetings:



ASCB
Philadelphia, PA
December 2-6, 2017